A case of iatrogenic severe mitral regurgitation
Journal article published in 2013 by
Antonio D'Aloia,
Barbara Piovanelli,
Riccardo Rovetta,
Ivano Bonadei,
Enrico Vizzardi,
Antonio Curnis,
Marco Metra 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson's disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.